
Patricia Ann Duffy
Examiner (ID: 259, Phone: (571)272-0855 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1818, 1802, 1806, 1648, 1645 |
| Total Applications | 1732 |
| Issued Applications | 766 |
| Pending Applications | 286 |
| Abandoned Applications | 682 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9759746
[patent_doc_number] => RE045170
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2014-09-30
[patent_title] => 'Streptococcus suis vaccines and diagnostic tests'
[patent_app_type] => reissue
[patent_app_number] => 14/015881
[patent_app_country] => US
[patent_app_date] => 2013-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 63
[patent_no_of_words] => 22438
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14015881
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/015881 | Streptococcus suis vaccines and diagnostic tests | Aug 29, 2013 | Issued |
Array
(
[id] => 11843453
[patent_doc_number] => 09730993
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-15
[patent_title] => 'Engineered anthrax lethal toxin for targeted delivery'
[patent_app_type] => utility
[patent_app_number] => 14/423408
[patent_app_country] => US
[patent_app_date] => 2013-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 23511
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 239
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14423408
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/423408 | Engineered anthrax lethal toxin for targeted delivery | Aug 21, 2013 | Issued |
Array
(
[id] => 10474853
[patent_doc_number] => 20150359869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-17
[patent_title] => 'METHODS AND COMPOSITIONS FOR PREVENTING A CONDITION'
[patent_app_type] => utility
[patent_app_number] => 14/422147
[patent_app_country] => US
[patent_app_date] => 2013-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 21964
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14422147
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/422147 | METHODS AND COMPOSITIONS FOR PREVENTING A CONDITION | Aug 13, 2013 | Abandoned |
Array
(
[id] => 9263153
[patent_doc_number] => 20130345082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'PEPTIDE NUCLEIC ACID PROBES FOR ANALYSIS OF CERTAIN STAPHYLOCOCCUS SPECIES'
[patent_app_type] => utility
[patent_app_number] => 13/955657
[patent_app_country] => US
[patent_app_date] => 2013-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10377
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13955657
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/955657 | PEPTIDE NUCLEIC ACID PROBES FOR ANALYSIS OF CERTAIN STAPHYLOCOCCUS SPECIES | Jul 30, 2013 | Abandoned |
Array
(
[id] => 9280301
[patent_doc_number] => 20140030269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => 'Staphylococcus aureus Specific Human Recombinant Polyclonal Antibodies and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/951645
[patent_app_country] => US
[patent_app_date] => 2013-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21545
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13951645
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/951645 | Staphylococcus aureus Specific Human Recombinant Polyclonal Antibodies and Uses Thereof | Jul 25, 2013 | Abandoned |
Array
(
[id] => 10347511
[patent_doc_number] => 20150232517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO'
[patent_app_type] => utility
[patent_app_number] => 14/412722
[patent_app_country] => US
[patent_app_date] => 2013-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 40890
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412722
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/412722 | MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO | Jul 7, 2013 | Abandoned |
Array
(
[id] => 10267132
[patent_doc_number] => 20150152129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'Synthetic Oligosaccharides for P. Aeruginosa Vaccine'
[patent_app_type] => utility
[patent_app_number] => 14/414971
[patent_app_country] => US
[patent_app_date] => 2013-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8569
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14414971
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/414971 | Synthetic Oligosaccharides for P. Aeruginosa Vaccine | Jul 2, 2013 | Abandoned |
Array
(
[id] => 10443260
[patent_doc_number] => 20150328272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'Compositions for Improving the Development of Arteriosclerotic Vascular Diseases'
[patent_app_type] => utility
[patent_app_number] => 14/410566
[patent_app_country] => US
[patent_app_date] => 2013-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12003
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14410566
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/410566 | Compositions for Improving the Development of Arteriosclerotic Vascular Diseases | Jun 16, 2013 | Abandoned |
Array
(
[id] => 10869829
[patent_doc_number] => 08895021
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-25
[patent_title] => 'Sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/914423
[patent_app_country] => US
[patent_app_date] => 2013-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23416
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13914423
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/914423 | Sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof | Jun 9, 2013 | Issued |
Array
(
[id] => 9093786
[patent_doc_number] => 20130273097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'USE OF SACCHARIDES CROSS-REACTIVE WITH BACILLUS ANTHRACIS SPORE GLYCOPROTEIN AS A VACCINE AGAINST ANTHRAX'
[patent_app_type] => utility
[patent_app_number] => 13/909992
[patent_app_country] => US
[patent_app_date] => 2013-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13261
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13909992
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/909992 | Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine against anthrax | Jun 3, 2013 | Issued |
Array
(
[id] => 9222475
[patent_doc_number] => 20140017251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'BOTULINUM NEUROTOXIN A RECEPTOR AND THE USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/902323
[patent_app_country] => US
[patent_app_date] => 2013-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13432
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13902323
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/902323 | Botulinum neurotoxin a receptor and the use thereof | May 23, 2013 | Issued |
Array
(
[id] => 9977059
[patent_doc_number] => 09023366
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-05
[patent_title] => 'Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)'
[patent_app_type] => utility
[patent_app_number] => 13/875958
[patent_app_country] => US
[patent_app_date] => 2013-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19552
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13875958
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/875958 | Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD) | May 1, 2013 | Issued |
Array
(
[id] => 9916761
[patent_doc_number] => 20150071966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-12
[patent_title] => 'RODENT PLASMODIUM PARASITES AS PLATFORMS FOR A WHOLE-ORGANISM MALARIA VACCINE'
[patent_app_type] => utility
[patent_app_number] => 14/394964
[patent_app_country] => US
[patent_app_date] => 2013-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5363
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14394964
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/394964 | Rodent plasmodium parasites as platforms for a whole-organism malaria vaccine | Apr 16, 2013 | Issued |
Array
(
[id] => 8964269
[patent_doc_number] => 20130203871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'FUIDI HERD MANAGEMENT SCHEMA'
[patent_app_type] => utility
[patent_app_number] => 13/837941
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10376
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13837941
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/837941 | FUIDI HERD MANAGEMENT SCHEMA | Mar 14, 2013 | Abandoned |
Array
(
[id] => 8837958
[patent_doc_number] => 20130133586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'FUIDI HERD MANAGEMENT SCHEMA'
[patent_app_type] => utility
[patent_app_number] => 13/751667
[patent_app_country] => US
[patent_app_date] => 2013-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8588
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13751667
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/751667 | FUIDI HERD MANAGEMENT SCHEMA | Jan 27, 2013 | Abandoned |
Array
(
[id] => 8951421
[patent_doc_number] => 20130197203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'Modified Polysaccharides for Conjugate Vaccines'
[patent_app_type] => utility
[patent_app_number] => 13/732861
[patent_app_country] => US
[patent_app_date] => 2013-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17660
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13732861
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/732861 | Modified Polysaccharides for Conjugate Vaccines | Jan 1, 2013 | Abandoned |
Array
(
[id] => 8989750
[patent_doc_number] => 20130217031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'GLYCEROGLYCOLIPID ANTIGEN OF MYCOPLASMA PNEUMONIAE'
[patent_app_type] => utility
[patent_app_number] => 13/729265
[patent_app_country] => US
[patent_app_date] => 2012-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11610
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13729265
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/729265 | GLYCEROGLYCOLIPID ANTIGEN OF MYCOPLASMA PNEUMONIAE | Dec 27, 2012 | Abandoned |
Array
(
[id] => 10892560
[patent_doc_number] => 08916170
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-23
[patent_title] => 'Methods of producing antibodies against morphine-heroine'
[patent_app_type] => utility
[patent_app_number] => 13/709507
[patent_app_country] => US
[patent_app_date] => 2012-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 19
[patent_no_of_words] => 19877
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13709507
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/709507 | Methods of producing antibodies against morphine-heroine | Dec 9, 2012 | Issued |
Array
(
[id] => 9015537
[patent_doc_number] => 20130230502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'METHODS OF TREATING CANCER USING OPIOD RETARGETED ENDOPEPIDASES'
[patent_app_type] => utility
[patent_app_number] => 13/682398
[patent_app_country] => US
[patent_app_date] => 2012-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 63277
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13682398
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/682398 | METHODS OF TREATING CANCER USING OPIOD RETARGETED ENDOPEPIDASES | Nov 19, 2012 | Abandoned |
Array
(
[id] => 14639131
[patent_doc_number] => 10364298
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-30
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 14/358927
[patent_app_country] => US
[patent_app_date] => 2012-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 12
[patent_no_of_words] => 14826
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358927
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/358927 | None | Nov 15, 2012 | Issued |